Opus Genetics, Inc. Operating Lease Cost
Opus Genetics, Inc. (IRD) reported Operating Lease Cost of $300.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-03-12
- Opus Genetics, Inc. operating lease, cost for the quarter ending 2025-12-31 was $100.00K, a 36.99% increase year-over-year.
- Opus Genetics, Inc. operating lease, cost for the quarter ending 2025-09-30 was $100.00K, a 1011.11% increase year-over-year.
- Opus Genetics, Inc. operating lease, cost for the quarter ending 2025-06-30 was $65.00K, a 622.22% increase year-over-year.
- Opus Genetics, Inc. operating lease, cost for the quarter ending 2025-03-31 was $67.00K, a 644.44% increase year-over-year.
- Opus Genetics, Inc. operating lease, cost for fiscal 2025 was $300.00K, a 200.00% increase from fiscal 2024.
- Opus Genetics, Inc. operating lease, cost for fiscal 2024 was $100.00K, a 177.78% increase from fiscal 2023.
- Opus Genetics, Inc. operating lease, cost for fiscal 2023 was $36.00K, a 7.69% decline from fiscal 2022.
- Opus Genetics, Inc. operating lease, cost for fiscal 2022 was $39.00K, a 66.38% decline from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 6 month as first filed | Operating Lease, Cost 9 month | Operating Lease, Cost 9 month as first filed | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $200.00K derived: sum of 2 quarters · filed 2026-03-12 | $265.00K derived: sum of 3 quarters · filed 2026-03-12 | $300.00K 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-12 | $165.00K derived: sum of 2 quarters · filed 2025-11-12 | $200.00K 10-Q · filed 2025-11-12 | $305.00K derived: sum of 4 quarters · filed 2026-03-12 | ||||
| 2025-06-30 | $65.00K 10-Q · filed 2025-08-13 | $132.00K 10-Q · filed 2025-08-13 | $205.00K derived: sum of 3 quarters · filed 2026-03-12 | $214.00K derived: sum of 4 quarters · filed 2026-03-12 | ||||
| 2025-03-31 | $67.00K 10-Q · filed 2025-05-15 | $140.00K derived: sum of 2 quarters · filed 2026-03-12 | $149.00K derived: sum of 3 quarters · filed 2026-03-12 | $158.00K derived: sum of 4 quarters · filed 2026-03-12 | ||||
| 2024-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $82.00K derived: sum of 2 quarters · filed 2026-03-12 | $91.00K derived: sum of 3 quarters · filed 2026-03-12 | $100.00K 10-K · filed 2026-03-12 | $140.00K 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $9.00K 10-Q · filed 2024-11-12 | $18.00K derived: sum of 2 quarters · filed 2025-08-13 | $27.00K 10-Q · filed 2024-11-12 | $36.00K derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-06-30 | $9.00K 10-Q · filed 2025-08-13 | $18.00K 10-Q · filed 2025-08-13 | $27.00K derived: sum of 3 quarters · filed 2025-08-13 | $36.00K derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $9.00K 10-Q · filed 2025-05-15 | $18.00K derived: sum of 2 quarters · filed 2025-05-15 | $27.00K derived: sum of 3 quarters · filed 2025-05-15 | $36.00K derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $18.00K derived: sum of 2 quarters · filed 2025-03-31 | $27.00K derived: sum of 3 quarters · filed 2025-03-31 | $36.00K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $9.00K 10-Q · filed 2024-11-12 | $18.00K derived: sum of 2 quarters · filed 2024-11-12 | $27.00K 10-Q · filed 2024-11-12 | $36.00K derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $9.00K 10-Q · filed 2024-08-13 | $18.00K 10-Q · filed 2024-08-13 | $27.00K derived: sum of 3 quarters · filed 2024-08-13 | $36.00K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $9.00K 10-Q · filed 2024-05-10 | $18.00K derived: sum of 2 quarters · filed 2024-05-10 | $27.00K derived: sum of 3 quarters · filed 2024-05-10 | $36.00K derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $18.00K derived: sum of 2 quarters · filed 2024-03-08 | $27.00K derived: sum of 3 quarters · filed 2024-03-08 | $39.00K 10-K · filed 2024-03-08 | ||||
| 2022-09-30 | $9.00K 10-Q · filed 2023-11-13 | $18.00K derived: sum of 2 quarters · filed 2023-11-13 | $30.00K 10-Q · filed 2023-11-13 | $39.00K derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $9.00K 10-Q · filed 2023-08-11 | $21.00K 10-Q · filed 2023-08-11 | $30.00K derived: sum of 3 quarters · filed 2023-08-11 | $39.00K derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $12.00K 10-Q · filed 2023-05-15 | $21.00K derived: sum of 2 quarters · filed 2023-05-15 | $30.00K derived: sum of 3 quarters · filed 2023-05-15 | $80.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $18.00K derived: sum of 2 quarters · filed 2023-03-30 | $68.00K derived: sum of 3 quarters · filed 2023-03-30 | $116.00K 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $9.00K 10-Q · filed 2022-11-04 | $59.00K derived: sum of 2 quarters · filed 2022-11-04 | $107.00K 10-Q · filed 2022-11-04 | $131.00K derived: sum of 4 quarters · filed 2022-11-04 | ||||
| 2021-06-30 | $50.00K 10-Q · filed 2022-08-12 | $98.00K 10-Q · filed 2022-08-12 | $122.00K derived: sum of 3 quarters · filed 2022-08-12 | $134.00K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $48.00K 10-Q · filed 2022-05-13 | $72.00K derived: sum of 2 quarters · filed 2022-05-13 | $84.00K derived: sum of 3 quarters · filed 2022-05-13 | $93.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $36.00K derived: sum of 2 quarters · filed 2022-03-24 | $45.00K derived: sum of 3 quarters · filed 2022-03-24 | $54.00K 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | $12.00K 10-Q · filed 2021-11-12 | $36.77K 10-Q · filed 2020-10-29 | $21.00K derived: sum of 2 quarters · filed 2021-11-12 | $30.00K 10-Q · filed 2021-11-12 | $110.31K 10-Q · filed 2020-10-29 | $94.54K derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $9.00K 10-Q · filed 2021-08-12 | $36.77K 10-Q · filed 2020-08-14 | $18.00K 10-Q · filed 2021-08-12 | $73.54K 10-Q · filed 2020-08-14 | $82.54K derived: sum of 3 quarters · filed 2021-08-12 | $119.31K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $36.77K 10-Q · filed 2020-05-07 | $73.54K derived: sum of 2 quarters · filed 2020-05-07 | $110.31K derived: sum of 3 quarters · filed 2020-10-29 | $157.44K derived: sum of 4 quarters · filed 2020-10-29 | ||||
| 2019-12-31 | $36.77K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $73.54K derived: sum of 2 quarters · filed 2020-10-29 | $120.67K derived: sum of 3 quarters · filed 2020-10-29 | $200.95K 10-K · filed 2020-02-21 | ||||
| 2019-09-30 | $36.77K 10-Q · filed 2020-10-29 | $83.90K derived: sum of 2 quarters · filed 2020-10-29 | $164.18K 10-Q · filed 2020-10-29 | |||||
| 2019-06-30 | $47.13K 10-Q · filed 2020-08-14 | $127.41K 10-Q · filed 2020-08-14 | ||||||
| 2019-03-31 | $80.28K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |